CompoAtlas

NMN

Natural health product licensed in Canada

Other names
TNC-NMN
Licence holder
TNC Ltd.
NPN or DIN-HM
80143302
Status
Active licence
Licence date
11 August 2025
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
3-(Aminocarbonyl)-1-(5-O-phosphonato-bêta -D-ribofuranosyl)pyridinium500 mgNot calculated
3,3'-Dihydroxy-bêta, bêta-carotène-4,4'-diène

Source : Haematococcus pluvialis - whole

10 mgNot calculated
Bromélaïne de fruit

Source : Ananas comosus var. comosus - fruit

480,000 FCC PUNot calculated
Vaccinium macrocarpon

Extract : Matériel brut frais

Extraction ratio : 10:1

Dry plant equivalent : 100 mg

10 mgNot calculated
5-[(1E)-2-(4-hydroxyphényl)éthényl]-1,3-benzènediol

Source : Reynoutria Japonica - racine

10 mgNot calculated
5-[(1E)-2-(4-hydroxyphényl)éthényl]-1,3-benzènediol

Source : Vitis vinifera - Fruit

10 mgNot calculated
2-(3,4-dihydroxyphényl)-3,5,7-trihydroxychromen-4-one

Source : Quercétine

10 mgNot calculated
Zingiber officinale

Source : Zingiber officinale - Rhizome

10 mgNot calculated
5,7-Dihydroxy-2-(4-hydroxyphényl)- 4H-1-benzopyran-4-one

Source : Apium graveolens - Graine

10 mgNot calculated
5,7-Dihydroxy-2-(4-hydroxyphényl)- 4H-1-benzopyran-4-one

Source : Bacopa monnieri - Sommité (herbe)

10 mgNot calculated
5,7-Dihydroxy-2-(4-hydroxyphényl)- 4H-1-benzopyran-4-one

Source : Cynara cardunculus - Feuille

10 mgNot calculated
Vaccinium myrtillus

Source : Vaccinium myrtillus - Fruit

10 mgNot calculated

Non-medicinal ingredients

Cellulose microcristalline, Dioxyde de silicium, Maltodextrine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Digestive enzyme. A factor in the maintenance of good health. NMN is a NAD+ precursor which helps to support biological functions which play a key role in the maintenance of good health. NMN is a NAD+ precursor which is a factor in normal growth and development. NMN is a NAD+ precursor which is an important cofactor in energy metabolism. Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of (an) antioxidant(s)/Provides (an) antioxidant(s). Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80143302

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line